Literature DB >> 17709897

The effects of glutamate can be attenuated by estradiol via estrogen receptor dependent pathway in rat adrenal pheochromocytoma cells.

Ching-Rong Chan1, Jih-Tay Hsu, I-tea Chang, Y-C Young, Chun-Ming Lin, Chingwen Ying.   

Abstract

Estrogens have been suggested to exhibit neuroprotective activities against several insults including beta-amyloid and glutamate, one of the excitatory neurotransmitters in the central nervous system. In the present study, we showed that exposure to glutamate not only inhibited the cell growth of exponentially growing rat pheochromocytoma PC12 cells in a time- and dose-dependent manner, but also influenced cell adherence capacity. Glutamate-induced growth inhibition was significantly attenuated by the co-administration of estradiol in PC12 cells. Pre-exposure of the PC12 cells to the estradiol was not required for protection against glutamate-induced growth inhibition. Administration of anti-estrogen ICI182,780 efficiently blocked the neuroprotective effects of estradiol. Glutamate-induced changes in cell adherence, on the other hand, were not significantly affected by estradiol. These data indicate that the neuroprotective effects of estradiol against glutamate-induced insults in PC12 cells, at least in part, involve estrogen receptor-dependent pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17709897     DOI: 10.1007/s12020-007-0010-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  46 in total

1.  Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in Vitro model for assessment of the neuroprotective effects of estrogens.

Authors:  L L Zaulyanov; P S Green; J W Simpkins
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

2.  Integrin signaling via the PI3-kinase-Akt pathway increases neuronal resistance to glutamate-induced apoptosis.

Authors:  D S Gary; M P Mattson
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

3.  Stroke in estrogen receptor-alpha-deficient mice.

Authors:  K Sampei; S Goto; N J Alkayed; B J Crain; K S Korach; R J Traystman; G E Demas; R J Nelson; P D Hurn
Journal:  Stroke       Date:  2000-03       Impact factor: 7.914

4.  Postmenopausal estrogen use and Parkinson's disease with and without dementia.

Authors:  K Marder; M X Tang; B Alfaro; H Mejia; L Cote; D Jacobs; Y Stern; M Sano; R Mayeux
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

5.  Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in female mouse.

Authors:  M Sawada; N J Alkayed; S Goto; B J Crain; R J Traystman; A Shaivitz; R J Nelson; P D Hurn
Journal:  J Cereb Blood Flow Metab       Date:  2000-01       Impact factor: 6.200

6.  Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease.

Authors:  C J Pike
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

7.  Growth factors and vitamin E modify neuronal glutamate toxicity.

Authors:  D Schubert; H Kimura; P Maher
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

8.  Expression of endogenous NMDAR1 transcripts without receptor protein suggests post-transcriptional control in PC12 cells.

Authors:  N J Sucher; N Brose; D L Deitcher; M Awobuluyi; G P Gasic; H Bading; C L Cepko; M E Greenberg; R Jahn; S F Heinemann
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

9.  Expression of N-methyl-D-aspartate receptor subunit mRNAs in the rat pheochromocytoma cell line PC12.

Authors:  C L Leclerc; C L Chi; M Awobuluyi; N J Sucher
Journal:  Neurosci Lett       Date:  1995-12-08       Impact factor: 3.046

10.  Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.

Authors:  G G Kuiper; J G Lemmen; B Carlsson; J C Corton; S H Safe; P T van der Saag; B van der Burg; J A Gustafsson
Journal:  Endocrinology       Date:  1998-10       Impact factor: 4.736

View more
  1 in total

1.  17β-estradiol delays 6-OHDA-induced apoptosis by acting on Nur77 translocation from the nucleus to the cytoplasm.

Authors:  Justine Renaud; Keith Chiasson; Julie Bournival; Claude Rouillard; Maria-Grazia Martinoli
Journal:  Neurotox Res       Date:  2013-11-26       Impact factor: 3.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.